This invention generally pertains to the field of psychiatry. In
particular, this invention pertains to the discovery that agents which
inhibit the binding of cortisol to its receptors can be used in methods
for treating delirium. Mifepristone, a potent specific glucocorticoid
receptor antagonist, can be used in these methods. The invention also
provides a kit for treating delirium in a human including a
glucocorticoid receptor antagonist and instructional material teaching
the indications, dosage and schedule of administration of the
glucocorticoid receptor antagonist.